Related Experiment Video
Updated: Nov 26, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene)
Sean DeAngelo1, Kailyn I Mann2, Muhammad Abdulbasit3
1University of South Florida/Lehigh Valley Hospital, 1200 South Cedar Crest Blvd, Allentown, PA, 18103, USA. seandea@pcom.edu.
Abstract:
Anti-neoplastic drugs have made major advancements in oncology, however they are not without cardiovascular consequences. We present a patient with cutaneous T-cell lymphoma receiving Targretin therapy who presented with accelerated atherosclerosis. His triglyceride level (TG) was greater than 1000 mg/dL, which rapidly improved with discontinuation of Targretin.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures

